FibroGen (FGEN) News Today $0.30 +0.00 (+0.20%) As of 05/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipelineMay 13 at 5:34 PM | msn.comFibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call TranscriptMay 13 at 5:34 PM | msn.comFibroGen, Inc.: FibroGen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13 at 5:53 AM | finanznachrichten.deFibroGen, Inc. (FGEN) Q1 2025 Earnings Call TranscriptMay 12 at 11:14 PM | seekingalpha.comFibroGen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 12 at 4:02 PM | globenewswire.comA Preview Of FibroGen's EarningsMay 10, 2025 | benzinga.comFibroGen (NASDAQ:FGEN) Earns Hold Rating from Analysts at StockNews.comMay 9, 2025 | americanbankingnews.comDuchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen)May 8, 2025 | globenewswire.comFibroGen, Inc. to Announce Q1 2025 Financial Results and Host Conference Call on May 12May 7, 2025 | nasdaq.comFibroGen to Report First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comWilliam Blair Keeps Their Hold Rating on FibroGen (FGEN)April 2, 2025 | markets.businessinsider.comFibroGen to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | globenewswire.comFibroGen extends merger option deadline with FortisMarch 30, 2025 | investing.comFibroGen announces publication of results from Phase 1 study of FG-3246March 29, 2025 | markets.businessinsider.comFibroGen Down on Peer-Review PublicationMarch 28, 2025 | baystreet.caInsider Buying: FibroGen, Inc. (NASDAQ:FGEN) CEO Purchases 145,000 Shares of StockMarch 26, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Director Buys $87,500.00 in StockMarch 25, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | msn.comFibroGen options imply 18.1% move in share price post-earningsMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 18, 2025 | finanznachrichten.deFibroGen reports Q4 EPS 18c, consensus (20c)March 18, 2025 | markets.businessinsider.comFibroGen (FGEN) Gets a Hold from William BlairMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc. (FGEN) Q4 2024 Earnings Call TranscriptMarch 17, 2025 | seekingalpha.comFibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 17, 2025 | globenewswire.comFibroGen to Report Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comFibroGen (FGEN) Expected to Announce Quarterly Earnings on MondayFibroGen (NASDAQ:FGEN) will be releasing earnings before the market opens on Monday, February 24.February 22, 2025 | marketbeat.comFibroGen (NASDAQ:FGEN) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $10.00 target price on shares of FibroGen in a research note on Thursday.February 21, 2025 | marketbeat.comStockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)StockNews.com began coverage on shares of FibroGen in a research report on Friday. They issued a "hold" rating for the company.February 21, 2025 | marketbeat.comFibroGen to sell China business, extend cash runway to focus on cancer drugsFebruary 21, 2025 | bizjournals.comFibroGen stock soars on China unit saleFebruary 20, 2025 | in.investing.comThis Small Cap Soared Following Subsidiary Sale Announcement Worth $160MFebruary 20, 2025 | msn.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | finance.yahoo.comFibroGen China sale ‘shrewd strategic transaction,’ says H.C. WainwrightFebruary 20, 2025 | markets.businessinsider.comFibroGen sells China unit to AstraZeneca in deal worth $160 millionFebruary 20, 2025 | reuters.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | globenewswire.comFibroGen, Inc. (NASDAQ:FGEN) Short Interest Down 5.2% in JanuaryFibroGen, Inc. (NASDAQ:FGEN - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,910,000 shares, a drop of 5.2% from the January 15th total of 3,070,000 shares. Based on an average daily volume of 1,250,000 shares, the days-to-cover ratio is currently 2.3 days.February 18, 2025 | marketbeat.comSeveral Insiders Invested In FibroGen Flagging Positive NewsFebruary 4, 2025 | finance.yahoo.comFibroGen (NASDAQ:FGEN) Shares Pass Above 50 Day Moving Average - Here's What HappenedFibroGen (NASDAQ:FGEN) Stock Price Passes Above Fifty Day Moving Average - What's Next?January 21, 2025 | marketbeat.comPerspective Therapeutics appoints Graham as CFOJanuary 7, 2025 | markets.businessinsider.comFibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on FibroGen in a research note on Wednesday. They set a "hold" rating for the company.January 1, 2025 | marketbeat.comFibroGen initiated with a Buy at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: FibroGen (FGEN) and Johnson & Johnson (JNJ)December 17, 2024 | markets.businessinsider.comFibroGen, Inc.: FibroGen Appoints David DeLucia as Chief Financial OfficerDecember 16, 2024 | finanznachrichten.deFibroGen Appoints David DeLucia as Chief Financial OfficerDecember 16, 2024 | globenewswire.comFibroGen (NASDAQ:FGEN) Stock, Option ChainNovember 15, 2024 | benzinga.comFibroGen Reports Strong Q3 Growth and Future PlansNovember 13, 2024 | markets.businessinsider.comFibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost ReductionsNovember 13, 2024 | finance.yahoo.comFibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call TranscriptNovember 12, 2024 | seekingalpha.comFibroGen Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | globenewswire.comFibroGen to Report Third Quarter 2024 Financial ResultsNovember 4, 2024 | globenewswire.com Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address FGEN Media Mentions By Week FGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FGEN News Sentiment▼-0.160.80▲Average Medical News Sentiment FGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FGEN Articles This Week▼101▲FGEN Articles Average Week Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fate Therapeutics News Today Theratechnologies News Today Alector News Today Alpha Cognition News Today Enanta Pharmaceuticals News Today Coherus BioSciences News Today Vigil Neuroscience News Today Compugen News Today Protalix BioTherapeutics News Today RAPT Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FGEN) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FGEN Stock Free FGEN Stock Alerts